Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Licitra

Showing results (161-170 of 311) with videos related to

Pageof 32
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 26, 2020
Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancerKenneth Emancipator, Lingkang Huang, Deepti Aurora-Garg, et al.
Tumori|May 2, 2018
Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancersCarlo Resteghini, Federica Perrone, Rosalba Miceli, et al.
Cancers|July 31, 2019
Mining of Self-Organizing Map Gene-Expression Portraits Reveals Prognostic Stratification of HPV-Positive Head and Neck Squamous Cell CarcinomaLaura D Locati, Mara S Serafini, Maria F Iannò, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studiesLisa Licitra, Stephan Störkel, Keith M Kerr, et al.
Oral Oncology|February 2, 2013
Tp53 status as guide for the management of ethmoid sinus intestinal-type adenocarcinomaPaolo Bossi, Federica Perrone, Rosalba Miceli, et al.
Oncotarget|December 10, 2017
RANK expression in EBV positive nasopharyngeal carcinoma metastasis: a ready-to-treat target?Carlo Resteghini, Salvatore Alfieri, Pasquale Quattrone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2021
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II TrialLaura D Locati, Stefano Cavalieri, Cristiana Bergamini, et al.
Oral Oncology|August 19, 2019
Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by ageNabil F Saba, George Blumenschein, Joel Guigay, et al.
Oral Oncology|July 26, 2021
The important role of cisplatin in the treatment of HPV-positive oropharyngeal cancer assessed by real-world data analysisIrene H Nauta, Thomas Klausch, Peter M van de Ven, et al.
Journal for Immunotherapy of Cancer|April 5, 2019
Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)Sara I Pai, Sandrine Faivre, Lisa Licitra, et al.
Pageof 32

Showing results (161-170 of 311) with videos related to

Sort By:
Pageof 32
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 26, 2020
Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancerKenneth Emancipator, Lingkang Huang, Deepti Aurora-Garg, et al.
Tumori|May 2, 2018
Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancersCarlo Resteghini, Federica Perrone, Rosalba Miceli, et al.
Cancers|July 31, 2019
Mining of Self-Organizing Map Gene-Expression Portraits Reveals Prognostic Stratification of HPV-Positive Head and Neck Squamous Cell CarcinomaLaura D Locati, Mara S Serafini, Maria F Iannò, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studiesLisa Licitra, Stephan Störkel, Keith M Kerr, et al.
Oral Oncology|February 2, 2013
Tp53 status as guide for the management of ethmoid sinus intestinal-type adenocarcinomaPaolo Bossi, Federica Perrone, Rosalba Miceli, et al.
Oncotarget|December 10, 2017
RANK expression in EBV positive nasopharyngeal carcinoma metastasis: a ready-to-treat target?Carlo Resteghini, Salvatore Alfieri, Pasquale Quattrone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2021
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II TrialLaura D Locati, Stefano Cavalieri, Cristiana Bergamini, et al.
Oral Oncology|August 19, 2019
Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by ageNabil F Saba, George Blumenschein, Joel Guigay, et al.
Oral Oncology|July 26, 2021
The important role of cisplatin in the treatment of HPV-positive oropharyngeal cancer assessed by real-world data analysisIrene H Nauta, Thomas Klausch, Peter M van de Ven, et al.
Journal for Immunotherapy of Cancer|April 5, 2019
Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)Sara I Pai, Sandrine Faivre, Lisa Licitra, et al.
Pageof 32